UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000025241
Receipt number R000029010
Scientific Title A Phase 2 study of concurrent combination therapy of TFTD (TAS-102) and bevacizumab in patients of more than 70 years of age with unresectable, advanced/recurrent colorectal cancer (KSCC 1602)
Date of disclosure of the study information 2016/12/13
Last modified on 2021/08/12 10:46:31

No. Disposal Last modified on Item of update
1 Insert 2016/12/13 01:48:17
2 Update 2016/12/14 09:23:26 Last name of lead principal investigator
Last name of lead principal investigator
Organization
3 Update 2017/01/13 14:04:43 Research ethics review
Institutions
4 Update 2017/06/13 12:20:58 Institutions
5 Update 2017/07/18 18:31:53 Control
6 Update 2017/12/13 17:03:27 Institutions
7 Update 2018/12/14 17:25:14 Email
Email
Email
8 Update 2019/01/06 17:08:17 Recruitment status
9 Update 2019/07/12 10:48:33 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Zip code
Address
Address
TEL
Email

Last name of contact person

Last name of contact person
Organization
Organization
Zip code
Address
TEL
Email
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
TEL
Email
Institute
Organization
Organization
Address
Address
Tel
Email
10 Update 2019/07/12 10:48:54 Number of participants that the trial has enrolled
11 Update 2019/07/12 10:52:42 Date of IRB
Last follow-up date
12 Update 2021/01/07 11:01:40 Recruitment status
13 Update 2021/08/12 10:46:31 URL releasing protocol
Publication of results
URL related to results and publications
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures